Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Bronconeumol. 2007 Jan;43(1):49-51.

[Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].

[Article in Spanish]

Author information

1
Servicio de Neumología, Hospital Xeral de Vigo, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España. rafaelbandres@yahoo.es

Abstract

Allergic bronchopulmonary aspergillosis is a lung disease characterized by an immune response to several antigens of Aspergillus species. Corticosteroids are the treatment of choice in the acute phase, although some studies have shown the efficacy of itraconazole. We describe the case of a favorable, prolonged therapeutic response to voriconazole in a patient with allergic bronchopulmonary aspergillosis who did not tolerate itraconazole.

PMID:
17257565
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ediciones Doyma, S.L.
    Loading ...
    Support Center